PMDA drug package insert
トルリシティ皮下注0.75mgアテオス
PMDA Prescription drug · 日本イーライリリー株式会社 · package insert Sep 15, 2026
Key facts
| Brand names | トルリシティ皮下注0.75mgアテオス, トルリシティ皮下注1.5mgアテオス |
|---|---|
| Nonproprietary names | デュラグルチド（遺伝子組換え） |
| Companies | 製造販売元／日本イーライリリー株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 持続性GLP-1受容体作動薬 |
| Therapeutic category codes | 872499 |
| YJ codes | 2499416G1029, 2499416G2025 |
| Approval numbers | 22700AMX00701, 30600AMX00141 |
| Package insert edition | 第12版 |
| Package insert date | Sep 15, 2026 |
| PMDA document key | 530471_2499416G1029_1 |
| PMDA company code | 530471 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: